Cirrus Therapeutics, Inc. research brief

CIK 2078601 Copy CIK

Generated Nov. 13, 2026, 6:41 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: Cambridge Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Aug. 19, 2025 · D · 0002070295-25-000002 · Source evidence

  Reported offering amount: 15698319 USD. Reported amount sold: 6698321 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Cirrus Therapeutics, Inc. research brief,” CIK 2078601, retrieved Nov. 13, 2026, 6:41 p.m.. Cite the specific accessions used. No amounts have been summed.